GENE ONLINE|News &
Opinion
Blog

2026-06-08|

Researchers Engineer Gene-Switch System Controlled by Sulfonylurea Herbicides

by GOAI
Share To

Researchers have engineered a new gene-switch system for field crops that responds to sulfonylurea herbicides by modifying the tetracycline repressor protein. This technology allows for the precise control of gene expression in plants using widely available agricultural chemicals, providing a potential tool for crop management and biotechnology applications.

The study details how scientists repurposed the tetracycline repressor—a protein typically used to regulate gene activity in bacteria—to recognize sulfonylurea herbicides instead of its original target. By altering the protein’s binding site, the team created a molecular switch that activates or deactivates specific genes when these herbicides are applied to the plant. The researchers tested these switches in various crop models to confirm that the system functions reliably under controlled conditions. This development offers a method for farmers and researchers to trigger specific genetic responses in crops by applying standard herbicide treatments, potentially simplifying the regulation of plant traits in field environments.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: June 8, 2026

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Author
Related Post
LATEST
YEARS Diagnostic Algorithm Reduces CTPA Scans by Over 20 Percent in Cancer Patients
2026-07-12
West Nile and Usutu Viruses Detected in Wild Carnivore Populations in the Netherlands
2026-07-11
Norwegian Stakeholders Identify Implementation Challenges in Elder Abuse Prevention Guidelines for 2026 BMC Geriatrics Study
2026-07-11
Norwegian Stakeholders Identify Implementation Challenges in Elder Abuse Prevention Guidelines for 2026 BMC Geriatrics Study
2026-07-11
Biotech Stock Performance Gap Widens During Second Quarter of 2026
2026-07-11
PYGO2 Overexpression Linked to Increased Plasma Cell Proliferation in Multiple Myeloma Patients with 1q21 Amplification
2026-07-10
Sean Kaufman Faces Senate Scrutiny Over Past Vaccine Safety Comments Ahead of Confirmation Hearing
2026-07-10
Scroll to Top